» Articles » PMID: 35334070

MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression

Overview
Date 2022 Mar 25
PMID 35334070
Authors
Affiliations
Soon will be listed here.
Abstract

Lung squamous cell carcinoma (LUSC) is one subtype of non-small-cell lung cancer, whose pathogenesis has not been fully understood. Exploring molecular mechanisms of LUSC helps a lot with the development of LUSC novel therapy. Hence, our study aims to investigate novel molecular mechanisms. Differentially expressed miRNAs and mRNAs were acquired from The Cancer Genome Atlas database. A series of assays were applied to test cell functions, including qRT-PCR to analyze RND1 and miR-4652-5p expression, dual-luciferase reporter gene assay to verify the targeting relationship between these two genes, cell counting kit-8 and colony formation assays to evaluate the ability of LUSC cells to proliferate, transwell to examine the migratory and invasive abilities, and western blot to test expression of RND1 and cell adhesion-related proteins. RND1 was lowly expressed while miR-4652-5p was highly expressed in LUSC cells. The correlation between these two genes was significantly negative and miR-4652-5p could downregulate RND1 expression. Additionally, cellular function assays validated that RND1 suppressed LUSC cells to proliferate, migrate, and invade. Besides, this gene might also affect cell adhesion. Furthermore, rescue assay suggested that miR-4652-5p downregulated RND1 expression to promote the progression of LUSC cells. Together, miR-4652-5p targeted RND1 to modulate cell adhesion and the progression of LUSC cells.

Citing Articles

Novel miRNA markers and their mechanism of esophageal squamous cell carcinoma (ESCC) based on TCGA.

Yuan P, Gao X, Xu M, Qiu L, Xiong Z, Shen J Sci Rep. 2024; 14(1):27261.

PMID: 39516222 PMC: 11549395. DOI: 10.1038/s41598-024-76321-0.


FOXA2 Activates RND1 to Regulate Arachidonic Acid Metabolism Pathway and Suppress Cisplatin Resistance in Lung Squamous Cell Carcinoma.

Zhou Y, Chen H, Yan J, Yao Q, Kong C, Peng Y Clin Respir J. 2024; 18(8):e13814.

PMID: 39129202 PMC: 11317498. DOI: 10.1111/crj.13814.

References
1.
Conti L, Gatt S . Squamous-Cell Carcinoma of the Lung. N Engl J Med. 2018; 379(11):e17. DOI: 10.1056/NEJMicm1802514. View

2.
Xu F, Zhang H, Chen J, Lin L, Chen Y . Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma. Int Immunopharmacol. 2019; 81:105932. DOI: 10.1016/j.intimp.2019.105932. View

3.
Okada T, Sinha S, Esposito I, Schiavon G, Lopez-Lago M, Su W . The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. Nat Cell Biol. 2014; 17(1):81-94. PMC: 4374353. DOI: 10.1038/ncb3082. View

4.
Chen X, Koh E, Yoder M, Gumbiner B . A protocadherin-cadherin-FLRT3 complex controls cell adhesion and morphogenesis. PLoS One. 2009; 4(12):e8411. PMC: 2791867. DOI: 10.1371/journal.pone.0008411. View

5.
Mitra R, Adams C, Jiang W, Greenawalt E, Eischen C . Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival. Nat Commun. 2020; 11(1):968. PMC: 7033124. DOI: 10.1038/s41467-020-14713-2. View